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Abstract 1 
Introduction: The impact of several dementia syndromes on activities of daily living (ADLs) 2 
has been well documented, but no study has yet investigated functional ability in posterior 3 
cortical atrophy (PCA). The primarily visual nature of deficits in this condition is likely to 4 
have a pronounced impact on ADLs. 5 
Objective: To profile functional change in PCA and identify predictors of change. 6 
Method: 29 PCA patients and 25 patients with typical Alzheimer’s disease (AD) and their 7 
caregivers were included in this cross-sectional study. ADLs were assessed using the 8 
Disability Assessment for Dementia (DAD), administered to caregivers, assessing basic 9 
ADLs (e.g. eating, dressing) and instrumental ADLs (e.g. managing finances, meal 10 
preparation). The predictive utility of cognitive domains (ACE), behavioural impairment 11 
(CBI-R) and demographic variables on ADL ability was also examined. 12 
Results: PCA patients showed significantly reduced total ADL scores compared to AD 13 
patients (medium effect size, d = -0.7; p<0.05), with significantly more impairment on basic 14 
ADLs (large effect size, d = -0.8; p<0.05), but similar impairment on instrumental ADLs 15 
(medium effect size, d = -0.5; p>0.05). A model combining patient mood, disinhibition, 16 
apathy, symptom duration, and memory and attention/orientation scores explained the 17 
variance of scores in functional decline (61.2%), but the key factor predicting ADL scores 18 
was attention/orientation (p=.048).   19 
Conclusion: This study shows the profound impact of PCA on ADLs and factors 20 
underpinning their disability. Attention/orientation deficits were found to correlate and 21 
contribute to variance in ADL scores. Future work to develop tailored interventions to 22 
manage ADL impairment in PCA should take these findings into account. 23 
 24 
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Introduction 25 
 26 
Establishing a diagnosis of dementia requires observation of a decline in cognition, and this 27 
decline must be severe enough to interfere with functional ability. Recently published 28 
consensus criteria for posterior cortical atrophy (PCA) (1) require this same evidence, 29 
representing a decline from a previous higher level of independent functioning. PCA is 30 
defined by a constellation of symptoms that fall broadly into the visual, perceptual and 31 
visuospatial domains (2, 3), alongside atrophy, hypometabolism or hypoperfusion 32 
predominantly in parieto-occipital or temporo-occipital cortices.  33 
 34 
Assessing ADLs reduces misdiagnosis based on over-interpretation of a change in cognition 35 
or sub-normal test scores, particularly in early stages. Functional measures have been shown 36 
to support early diagnosis of syndrome specific cognitive changes (4, 5), track the 37 
longitudinal course of disease (6, 7), inform tailored interventions to support independent 38 
living (8), and indicate caregiver outcomes (8). Regulatory guidelines for pharmacological 39 
trials in dementia recommend the incorporation of ADL scales to detect meaningful and 40 
ecologically valid change, as well as assess the efficacy of an intervention. 41 
 42 
ADLs are typically divided into basic activities, (e.g. eating) and instrumental activities, 43 
comprising more complex tasks (e.g. managing finances) (9). The impact of several dementia 44 
syndromes on ADLs has been well documented, showing broadly that instrumental ADLs are 45 
more affected than basic ADLs (e.g. (4)). Few studies have been undertaken to describe how 46 
a diagnosis of PCA impacts ADLs. Shakespeare et al. (10) used the Cambridge Behavioural 47 
Inventory to show a loss of independence in everyday skills and self-care, and cases studies 48 
(11, 12) support this finding of a loss of autonomy. The primarily visual nature of deficits in 49 
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PCA are likely to have a pronounced impact on ADLs and thus a more extensive profile of 50 
impairment is needed. 51 
 52 
The aim of this study was to determine (i) the profile of functional change in PCA, and (ii) 53 
the predictive utility of cognition, behavioural and demographic variables on overall ADL 54 
ability.  55 
 56 
Materials and Methods 57 
 58 
Participants 59 
 60 
29 PCA patients and caregivers were recruited through the Oxford Cognitive Disorders Clinic 61 
at the John Radcliffe Hospital, Oxford, UK between 2014 and 2017. PCA patients were 62 
compared with 25 tAD patients, included as a patient control group, recruited from the Early 63 
Onset Dementia Clinic, at Addenbrooke’s Hospital, Cambridge, UK, from May 2004 to 64 
2006. The data from these tAD patients have previously been published(4). Diagnosis was 65 
established by a senior behavioural neurologist (CRB, ST or MH in Oxford, and JRH in 66 
Cambridge). All patients fulfilled consensus criteria for PCA (1) or tAD (13, 14), based upon 67 
clinical assessment, brain imaging and detailed neuropsychological assessment. Clinical 68 
magnetic resonance imaging (MRI) confirmed hallmark focal atrophy in the occipital and 69 
parietal lobes in PCA and bilateral medial temporal lobe atrophy in tAD. Patient groups were 70 
matched for age, years of education, gender distribution and symptom duration, i.e. time 71 
since the first symptom was noticed (all p values >.05; Table 1).  72 
 73 
Patients were included into the study if they (i) had a caregiver, defined as a person who was 74 
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able to give a reliable account of the patient’s routine, either from sharing a residence or close 75 
involvement in the patient’s everyday life; and (ii) did not have any additional physical 76 
disability that would confound assessment of ADLs. 77 
 78 
-Table 1 here- 79 
 80 
Assessment measures 81 
 82 
Functional assessment. ADLs were assessed using the Disability Assessment for Dementia 83 
(DAD; (9)), an informant-based scale consisting of 40 items which has been extensively used 84 
in dementia cohorts (e.g. frontotemporal dementia, Alzheimer’s disease (4), primary 85 
progressive aphasia (6)) and atypical parkinsonian syndromes (15). Seventeen items relate to 86 
basic ADLs, divided into questions about hygiene, dressing, continence and eating. Twenty-87 
three items relate to instrumental ADLs asking about meal preparation, telephoning, going on 88 
an outing, finance and correspondence, medications and leisure and housework. Lower scores 89 
on the DAD denote greater impairment. Non-applicable questions are excluded from the total 90 
score, avoiding gender bias toward activities (e.g., cooking, house chores, finances), and 91 
scores are converted to percentages. Caregivers responded by considering the patients’ ability 92 
to conduct each activity independently, without help or reminder, in the last two weeks. 93 
Brief cognitive assessment. The Addenbrooke’s Cognitive Examination-III (ACE-III) (16) 94 
assesses five domains: attention and orientation, memory, verbal fluency, language and 95 
visuospatial abilities.  96 
Behavioural outcomes. Questions pertaining to abnormal behaviour, mood and motivation 97 
from the Cambridge Behavioural Inventory-Revised (CBI-R; (17)) were used to assess 98 
behavioural change. CBI-R scores were converted to percentages for ease of comparison 99 
7 
 
across domains that have an unequal number of questions. Higher percentages denote more 100 
impairment. 101 
 102 
Statistical analyses 103 
 104 
Demographic and cognitive characteristics of patient groups (PCA vs tAD) were explored 105 
using independent sample t-tests and nonparametric Mann-Whitney tests for pairwise 106 
comparisons, as appropriate. Chi-squared test was used to explore gender differences 107 
between groups.  108 
  109 
Further analysis was restricted to the PCA group as the patient group of interest and due to 110 
lack of available comparison data in the AD group. The predictive value of cognitive (ACE 111 
memory, fluency, attention/orientation, language and visuospatial skills), behavioural (CBI-R 112 
domains, namely: disinhibition, apathy and mood) and demographics variables (age and 113 
symptom duration) was explored using univariate linear regression analyses, and any 114 
variables not normally distributed were log transformed for this purpose. Significant 115 
predictors were subsequently entered into a multiple linear regression analysis (Enter 116 
method) to determine the relative contribution of each predictor to total DAD score.  117 
For all between group comparisons, Cohen’s d was used to estimate effect size: d = 0.2 118 
(small effect size); d = 0.5 (medium effect size); d = 0.8 (large effect size) (18). Significance 119 
level was set at p≤0.05, 95%, Confidence Interval (95%CI). All analyses were performed 120 
using the Statistical Package for the Social Sciences (SPSS) 21.0 version (IBM Inc., Chicago, 121 
Illinois, USA).  122 
 123 
Data availability 124 
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Anonymized data, related documents such as study protocol, and statistical analysis will be 125 
shared for legitimate research, by direct request from the principal author at 126 
samrah.ahmed@ndcn.ox.ac.uk. 127 
 128 
Results 129 
 130 
Profile of ADLs in PCA compared to AD 131 
 132 
DAD total scores. PCA patients showed significantly lower DAD scores than tAD patients, 133 
reflecting more severe disability to perform ADLs independently (medium effect size, d= -0.7, 134 
p<0.05) (Table 1).  135 
 136 
Basic ADLs and Instrumental ADLs. PCA patients were significantly more impaired than  137 
tAD patients on basic ADLs (large effect size, d = -0.8, p<0.05), but there was no significant 138 
difference between groups on instrumental ADLs performance (medium effect size d = -0.5, 139 
p>0.05). Examining the difference between basic ADLs and instrumental ADLs within each 140 
group, PCA and tAD patients were both significantly more impaired on instrumental ADLs 141 
compared to basic ADLs, as expected.  142 
 143 
To investigate the clinical implications of these dementia subtypes on everyday living, 144 
patients were classified according to their level of impairment on basic ADLs and 145 
instrumental ADLs. The method of classification was as follows (4): 100% = ‘no change’; 146 
70-99% = ‘marginal to mild impairment’; 30-69% = ‘moderate to severe impairment’; 0-29% 147 
= ‘severe to very severe impairment’. Of note, both dementia subgroups had similar duration 148 
of symptoms (Table 1).  149 
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 150 
While the majority of patients with PCA (~60%) had no change or mild impairment in basic 151 
ADLs, 20% of patients had severe impairment in basic ADLs. By contrast, no AD patient had 152 
severe impairment in basic ADLs in this study. The great majority of patients with AD and 153 
PCA had moderate to severe impairment in instrumental ADLs (Figure 1b). Of note, one 154 
PCA patient did not have any impairment in ADLs on the DAD. Close inspection of the data 155 
revealed that this person was very early in the disease course (less than 24 months) and both 156 
patient and carer were still in paid employment. The carer may not therefore have judged 157 
there to be marked ADL impairment.  158 
 159 
- Insert Figure 1 here - 160 
 161 
Qualitative patterns of disability in patients with PCA 162 
For a greater understanding of clinical and care issues in patients with PCA, we plotted 163 
patients according to their levels of performance in ten different types of ADLs, according to 164 
their scores on the DAD: hygiene, continence, eating, dressing, leisure and housework, 165 
managing medications, going on an outing, telephoning, meal preparation and managing 166 
finances and correspondence. In addition, we split the patients into three groups according to 167 
their length of symptoms (1-3 years; 4-6 years; 8 years+).  168 
 169 
Figure 2 shows that early in the disease course, patients with PCA are likely to have greater 170 
difficulties in the management of finances and correspondence, as well as meal preparation, 171 
with a gradient of difficulties on other basic activities. Later in the disease progression, this 172 
gradient seems to flatten and patients seem to be largely impaired across both instrumental 173 
and basic ADLs, confirming a greater level of dependency to perform ADLs.  174 
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 175 
- Insert Figure 2 here – 176 
 177 
Predictors of ADL ability in patients with PCA 178 
Univariate regression analyses were used to investigate the utility of cognitive (ACE 179 
domains: attention/orientation, memory, fluency, language and visuospatial skills), behavioral 180 
(CBI-R domains: disinhibition, mood and apathy) and demographic variables (age and 181 
symptom duration) to predict ADL performance (DAD total) in patients with PCA. ACE 182 
attention/orientation (p=.004), ACE memory (p=.024), CBI-R disinhibition (p=.003), CBI-R 183 
mood (p=.006), CBI-R apathy (p=.008) and symptom duration (p=.001) were significantly 184 
correlated with total DAD score. Next, a multiple regression analysis was run to predict DAD 185 
total score from these significant factors. Overall, the model significantly predicted DAD 186 
total scores (F(6,13)=3.424, p=.030, R2=.612), accounting for 61.2% of the variance. Only 187 
ACE attention/orientation score added significance to the overall prediction of the model 188 
(p=.048). Secondary exploratory analysis was conducted to examine whether floor/ceiling 189 
effects on the ACE subdomains may have skewed the association with the DAD. 190 
Representative scatterplots (Figure 3) show that there was variability in cognitive 191 
performance across domains, however, visuospatial assessment did suffer from a floor effect. 192 
This is likely to be a contributory factor to the lack of association between ADL and 193 
visuospatial measures. 194 
 195 
- Insert Figure 3 here - 196 
 197 
Discussion/Conclusion 198 
 199 
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This study details a novel investigation of how everyday functional ability is affected by 200 
PCA. PCA patients were impaired in ADLs to a greater extent than the tAD group despite the 201 
two groups being matched for symptom duration. On basic ADLs, a larger proportion of PCA 202 
patients showed impairment than tAD patients. These changes were also more severe in PCA, 203 
where 41.4% of patients had ‘moderate to very severe’ impairment compared to only 8% of 204 
tAD patients, and no tAD patients showed ‘severe to very severe’ impairment. All tAD 205 
patients were impaired on instrumental ADLs. The majority of PCA patients showed 206 
‘moderate to severe impairment’, with a higher proportion than tAD showing the most severe 207 
impairment. Both patient groups were more impaired on instrumental ADLs than on basic 208 
ADLs, as would be expected given the more complex requirements of instrumental ADLs.  209 
 210 
We predicted that these changes in ADLs would be, in some part, related to the salient visual 211 
deficits in PCA. However, no relationship between ADLs and the visuospatial scores was 212 
identified. Examination of individual scores showed that several patients scored at floor on 213 
visuospatial assessment, compared to more varied scores in other domains. As such, it is not 214 
possible to conclude that impaired visuospatial scored are not a predictor of ADL scores. The 215 
brief visuospatial assessment in the ACE is not able to capture the variability of visual 216 
deficits in PCA. A broader visuospatial assessments is likely to have drawn out a relationship 217 
with ADLs. Memory scores and, in particular, attention/orientation were predictive of overall 218 
DAD score. We have recently demonstrated that attention and memory may be impaired 219 
early on in PCA (19-21), perhaps related to the crucial role of the parietal lobes in these 220 
cognitive functions. Such cognitive changes would intuitively interfere with a person’ ability 221 
to undertake everyday tasks. The clinical implications are compelling, highlighting the need 222 
to examine changes in attention and memory in PCA, in addition to the salient and defining 223 
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visual disorder, in order to be able to predict and potentially monitor disease impact on 224 
ADLs.  225 
 226 
ADLs were significantly associated with disease duration, showing that as disease progresses 227 
over time, proficiency in instrumental ADLs and basic ADLs decreases. This shows that 228 
functional assessment can be used as an indicator of functional deterioration from the early 229 
stages to later more severe stages of impairment in PCA. Sensitivity to early changes within a 230 
short duration of symptoms was particularly striking and highlights the detrimental impact of 231 
the initial symptomatology in PCA on a range of everyday tasks, both basic and complex. 232 
This information is particularly useful for healthcare professionals and families by indicating 233 
where PCA patients will encounter problems early in the disease process and thus where 234 
early interventions can be targeted. 235 
 236 
Finally, behavioural changes contributed to the model explaining the variance of overall 237 
DAD scores in PCA patients. Low mood is a common accompaniment to dementia (22) and 238 
in PCA specifically, is considered as being reactive to diagnosis (1). The significant 239 
relationship with overall ADL ability suggests that assessment and monitoring of depressive 240 
symptoms in patients should be considered, and a low threshold for treatment to help prevent 241 
premature loss of independence in ADLs. Likewise, apathy is a commonly associated with 242 
several conditions (see (23) for a recent review), including Alzheimer’s disease. Apathy is 243 
related to poor outcomes for both the patient and caregiver, including predicting functional 244 
impairment in AD (24) and other dementias (8), and here we show a similar relationship with 245 
independent function in PCA. Apathy may be amenable to intervention (25), and again the 246 
potential clinical implications warrant more research. 247 
 248 
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 249 
One limitation of the study was that pathological confirmation of diagnosis was not available 250 
in PCA, in particular. Although the most common underlying cause is Alzheimer’s pathology 251 
(26), in a minority of cases alternative aetiologies, including corticobasal degeneration, 252 
dementia with Lewy bodies and prion disease, are implicated (1). Different aetiologies may 253 
well have a differential impact on ADLs. Furthermore, informant-based measures are subject 254 
to bias and may over- or underestimate a patient’s actual ability, although the DAD is a 255 
widely used and well-validated measure. Further work should consider acquiring supportive 256 
data from performance-based measures to gain an independent and more accurate measure of 257 
ADL performance. 258 
 259 
In summary, this study shows the pronounced impact of PCA on ADLs. The DAD emerges 260 
as a sensitive tool to assess functional impairment in PCA and one that may be able to 261 
monitor change as disease progresses. ADL measures tend to benefit from a relative absence 262 
of gender, language and cultural bias since their ratings are based on the individuals’ 263 
premorbid functioning, further broadening its clinical utility in improving diagnostic and 264 
outcome assessment. Further work is warranted to determine how ADL measures can be used 265 
to assist the development of tailored interventions and management strategies for PCA 266 
patients. 267 
 268 
  269 
14 
 
Statements 270 
Acknowledgements 271 
We are indebted to the patients and families for their kind participation in our research. 272 
Thanks to Cristina Blanco-Duque for help with data collection.  273 
 274 
Statement of Ethics 275 
The study was approved by the National Research Ethics Service South Central - Hampshire 276 
B and Oxford C. Secondary Cambridge data collection (tAD) was approved through the 277 
Cambridge Local Research Ethics Committee. All participants provided written informed 278 
consent in accordance with the Declaration of Helsinki.  279 
 280 
Disclosure statement 281 
JRH is a member of the advisory boards for Nature Reviews and Neurology, both in a non-282 
profit capacity; serves on the editorial boards of Aphasiology (2000 - ), Cognitive 283 
Neuropsychology (2002- ), Nature Reviews (2005 - ), Journal of Alzheimer’s Disease, 284 
Associate Editor (2010 - ), Acta Neuropsychologica (2011 - ), ALS Journal (2011- ), an 285 
Neurology and Clinical Neuroscience (NCN) (2013); receives publishing royalties for OUP, 286 
Cognitive Assessment for Clinicians (OUP 2007) and Frontotemporal dementia Syndromes 287 
(CUP 2007). EM receives funding support from the Alzheimer’s Society and CLAHRC East 288 
of England. The remaining authors have no conflicts of interest to declare. 289 
 290 
Funding sources 291 
15 
 
This study was funded by Alzheimer’s Research UK and Medical Research Council 292 
(MR/K010395/1). 293 
 294 
Author contributions 295 
SA contributed to the design and conceptualization of the study, analysis and interpretation of 296 
data, data collection, drafting and revision of the manuscript and study supervision. SC 297 
contributed to analysis of data, data collection, and drafting and revision of the manuscript. 298 
CBD contributed to data collection, and drafting and revision of the manuscript. JRH 299 
contributed to the drafting and revision of the manuscript. CB contributed to drafting and 300 
revision of the manuscript and study supervision. EM contributed to the design and 301 
conceptualization of the study, analysis and interpretation of data, data collection, drafting 302 
and revision of the manuscript and study supervision. 303 
16 
 
 
REFERENCES 
 
1. Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, et al. 
Consensus classification of posterior cortical atrophy. Alzheimer's & dementia : the journal of the 
Alzheimer's Association. 2017;13(8):870-84. 
2. McMonagle P, Deering F, Berliner Y, Kertesz A. The cognitive profile of posterior cortical 
atrophy. Neurology. 2006;66(3):331-8. 
3. Tang-Wai DF, Graff-Radford NR, Boeve BF, Dickson DW, Parisi JE, Crook R, et al. Clinical, 
genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 
2004;63(7):1168-74. 
4. Mioshi E, Kipps CM, Dawson K, Mitchell J, Graham A, Hodges JR. Activities of daily living in 
frontotemporal dementia and Alzheimer disease. Neurology. 2007;68(24):2077-84. 
5. O'Connor CM, Landin-Romero R, Clemson L, Kaizik C, Daveson N, Hodges JR, et al. 
Behavioral-variant frontotemporal dementia: Distinct phenotypes with unique functional profiles. 
Neurology. 2017;89(6):570-7. 
6. Jang J, Cushing N, Clemson L, Hodges JR, Mioshi E. Activities of daily living in progressive 
non-fluent aphasia, logopenic progressive aphasia and Alzheimer's disease. Dement Geriatr Cogn 
Disord. 2012;33(5):354-60. 
7. O'Connor CM, Clemson L, Hornberger M, Leyton CE, Hodges JR, Piguet O, et al. Longitudinal 
change in everyday function and behavioral symptoms in frontotemporal dementia. Neurol Clin 
Pract. 2016;6(5):419-28. 
8. O’Connor C, Ahmed S, Mioshi E. Functional disability in primary progressive aphasia. 
Aphasiology. 2014;28(8-9):1131-49. 
9. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental 
activities of daily living. Gerontologist. 1969;9(3):179-86. 
10. Shakespeare TJ, Yong KX, Foxe D, Hodges J, Crutch SJ. Pronounced impairment of everyday 
skills and self-care in posterior cortical atrophy. J Alzheimers Dis. 2015;43(2):381-4. 
11. Bier N, El-Samra A, Bottari C, Vallet GT, Carignan M, Pagnette G, et al. Posterior cortical 
atrophy: Impact on daily living activitise and exploration of a cognitive rehabilitation approach. 
Cogent Psychology. 2019;6(1). 
12. Weill-Chounlamountry A, Poncet E, Crop S, Hesly N, Pradat-Diehl P. Multidisciplinary 
rehabiliatation in a case of posterior cortical atrophy. Annals of Physical and Rehabilitation Medicine. 
2012;55(s1). 
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of 
Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of 
Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-44. 
14. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, et al. The 
diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on 
Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. 
Alzheimer's & dementia : the journal of the Alzheimer's Association. 2011;7(3):263-9. 
15. Cushing N, Jang J, O'Connor CM, Burrell JR, Clemson L, Hodges JR, et al. Disability in atypical 
parkinsonian syndromes is more dependent on memory dysfunction than motor symptoms. 
Parkinsonism Relat Disord. 2013;19(4):436-40. 
16. Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke's Cognitive 
Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 
2013;36(3-4):242-50. 
17 
 
17. Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, Hodges J, et al. The utility of the 
Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry. 
2008;79(5):500-3. 
18. Cohen J. Statistical power analysis for the behavioural sciences: Routledge; 1977. 
19. Ahmed S, Baker I, Husain M, Thompson S, Kipps C, Hornberger M, et al. Memory Impairment 
at Initial Clinical Presentation in Posterior Cortical Atrophy. J Alzheimers Dis. 2016;52(4):1245-50. 
20. Ahmed S, Irish M, Loane C, Baker I, Husain M, Thompson S, et al. Association between 
precuneus volume and autobiographical memory impairment in posterior cortical atrophy: Beyond 
the visual syndrome. Neuroimage Clin. 2018;18:822-34. 
21. Ahmed S, Loane C, Bartels S, Zamboni G, Mackay C, Baker I, et al. Lateral parietal 
contributions to memory impairment in posterior cortical atrophy. Neuroimage Clin. 2018;20:252-9. 
22. Enache D, Winblad B, Aarsland D. Depression in dementia: epidemiology, mechanisms, and 
treatment. Curr Opin Psychiatry. 2011;24(6):461-72. 
23. Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat 
Rev Neurosci. 2018;19(8):470-84. 
24. Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. Executive 
dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry. 
2003;11(2):214-21. 
25. Brodaty H, Burns K. Nonpharmacological management of apathy in dementia: a systematic 
review. Am J Geriatr Psychiatry. 2012;20(7):549-64. 
26. Renner JA, Burns JM, Hou CE, McKeel DW, Jr., Storandt M, Morris JC. Progressive posterior 
cortical dysfunction: a clinicopathologic series. Neurology. 2004;63(7):1175-80. 
 
  
18 
 
FIGURE LEGENDS 
Figure 1.  
Title: IADLs and BADLs in PCA and tAD. Legend: Distribution of patient according to 
severity of impairment on (A) Basic activities of daily living; and (B) Instrumental activities 
of daily living. Abbreviations: PCA Posterior cortical atrophy; tAD typical Alzheimer’s 
disease. 
 
Figure 2. 
Title: ADLs stratified by symptom duration. Lower scores (%) denote greater impairment. 
Legend: Comparison of BADLs and IADLs in PCA, stratified by symptom duration. 
Abbreviations: BADLs Basic Activities of Daily Living, IADLs Instrumental Activities of 
Living. 
 
Figure 3. 
Title: Scatterplots depicting association between DAD total score and ACE subdomains in 
PCA patients. 
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